ÂÜÀòÂÒÂ×

Sarabjit Ashta is currently the Chief Business Officer at Glycadia Pharmaceuticals, a company focused on developing therapeutics for diabetes-related complications. Prior to this role, Ashta held positions such as Vice President at Dr. Reddy's Laboratories, Sr. Director at Endo Pharmaceuticals, Director at Biogen Idec, Inc., and Director at Becton Dickinson. Ashta's career in corporate development and strategic planning spans over several reputable companies such as Sumitomo Bank. Ashta holds an MBA in International Finance from New York University and a B.Sc. in Mathematical Economics and Econometrics from The London School of Economics and Political Science (LSE).